MedPath

Impact of Photopheresis in the Prevention of Acute Rejection in Highly Sensitized de Novo Kidney Transplant Recipients

Not Applicable
Recruiting
Conditions
Kidney Transplant Rejection
Registration Number
NCT04414735
Lead Sponsor
Fundacion Clinic per a la Recerca Biomédica
Brief Summary

The aim of the present study is to evaluate the superiority of photopheresis in combination with the standard immunosuppression vs standard immunosuppression alone for the prevention of acute rejection in highly sensitized kidney transplant recipients (cPRA ≥90%).

Unicentric, randomized, open study.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Sensitized (cPRA ≥90%) candidates for a deceased-donor kidney transplantation
  • Recipients between 18 and 75 years old
  • Patients are able to understand and sign informed consent (Annex 1).
Exclusion Criteria
  • Participation in another interventional clinical trial.
  • Use of Rituximab or Eculizumab at the time of transplant or in the first 24 hours post-transplant.
  • Persons with any dependency on the researcher or employee by the responsible institution or researcher. As well as people detained by legal order.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Time to first histological rejection in the first year of kidney transplantation.1 year after kidney transplantation

Time to first histological rejection in the first year of kidney transplantation.

Secondary Outcome Measures
NameTimeMethod
Biopsy proved acute rejection1 year after kidney transplantation
Glomerular filtrate rate at one year after kidney transplant1 year after kidney transplantation

Trial Locations

Locations (1)

Deparment of Nephology and Kidney Transplant

🇪🇸

Barcelona, Please Select, Spain

Deparment of Nephology and Kidney Transplant
🇪🇸Barcelona, Please Select, Spain
Gastón J Piñeiro, MD
Sub Investigator
Fritz Diekmann, MD, PhD
Contact
+34932275400
fdiekman@clinic.cat
Fritz Diekmann, MD,PhD
Principal Investigator
Jordi Rovira, PhD
Sub Investigator
Pedro Ventura, MD, PhD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.